AAP issues guidelines for preventing group B streptococcal infections.
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008403:Mass Screening; D015997:Neonatal Screening; D010372:Pediatrics / Q000379:methods / Q000592:standards*; D012307:Risk Factors; D012955:Societies, Medical; D013290:Streptococcal Infections / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control*; D013292:Streptococcus agalactiae; D014481:United States / Q000453:epidemiology
D000900:Anti-Bacterial Agents